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Antigenic stimulation of the B-cell receptor (BCR) is a
central event in the immune response. In contrast, anti-
gen bound to IgG negatively regulates signals from the
BCR by cross-linking it to the inhibitory receptor
FcgRIIB. Here we show that upon cross-linking of BCR
or BCR with FcgRIIB, the rasGAP-associated protein
p62dok is prominently tyrosine phosphorylated in a Lyn-
dependent manner. Inactivation of the dok gene by ho-
mologous recombination has shown that upon BCR
cross-linking, p62dok suppresses MAP kinase and is in-
dispensable for FcgRIIB-mediated negative regulation of
cell proliferation. We propose that p62dok, a downstream
target of many PTKs, plays a negative role in various
signaling situations.
Received September 27, 1999; revised version accepted
November 18, 1999.
The p120 rasGAP-associated p62 protein was originally
defined as a tyrosine-phosphorylated 62-kD protein co-
immunoprecipitated with p120 rasGAP, a negative regu-
lator of p21ras (Ellis et al. 1990; White and Yenush 1998).
A p62 is tyrosine phosphorylated downstream of a wide
range of protein-tyrosine kinases (PTKs), such as recep-
tors for platelet-derived growth factor (PDGF), colony
stimulating factor-1 (CSF-1), insulin, insulin-like growth
factor (IGF), Kit ligand, and vascular endothelial growth
factor (VEGF) or oncoproteins like Bcr–Abl, a causative
factor of chronic myelogenous leukemia(CML)(Carpino
et al. 1997; Yamanashi and Baltimore 1997; White and
Yenush 1998; Noguchi et al. 1999). A p62 is also tyrosine
phosphorylated downstream of receptors coupled with
cytoplasmic PTKs. We and others have independently
purified a p62 from v-Abl- or Bcr–Abl-transformed hema-
topoietic cells and identified it as a docking protein
(Dok) (Carpino et al. 1997; Yamanashi and Baltimore
1997). p62dok has overall structural similarity to insulin
receptor substrate-1 (IRS-1), having both pleckstrin ho-
mology (PH) and phosphotyrosine binding (PTB) do-
mains in its amino-terminal portion, followed by many
binding sites for SH2 domains (Carpino et al. 1997; Ya-
manashi and Baltimore 1997; White and Yenush 1998).
IRS-1 binds to activated and autophosphorylated insulin
receptor through its amino-terminal PH and PTB do-
mains and is subsequently tyrosine phosphorylated, al-
lowing its carboxy-terminal region to act as docking sites
for SH2-containing signaling molecules such as PI-3 ki-
nase (White and Yenush 1998). p62dok appears to recruit
a set of SH2-containing proteins different from those re-
cruited by IRS-1 (Carpino et al. 1997; Yamanashi and
Baltimore 1997; Noguchi et al. 1999); when tyrosine
phosphorylated, it binds to rasGAP, Nck, and probably
other SH2-containing proteins. Although it was recently
found that ectopic overexpression of p62dok in a cell line
up-regulates motility of the cells (Noguchi et al. 1999),
the physiological function of p62dok has yet to be re-
vealed. We have therefore generated a null mutation in
the mouse dok gene and have studied the physiological
role of p62dok in primary B cells.
Results and Discussion
To address the role of p62dok, we have generated a null
mutation in the dok gene, in which the entire coding
sequence of the gene was deleted by homologous recom-
bination (Fig. 1A). dok−/− mice did not express the dok
protein (Fig. 1B,C). Such mice were fertile and have lived
at least 1 year with normal populations of hematopoietic
cells. In the equivalent cells of normal mice, however,
the dok gene is expressed at relatively high level (data
not shown). It might be that dok-related gene(s) such as
dok-2/frip/dok-R can compensate for the inactivated
dok gene (Di Cristofano et al. 1998; Jones and Dumont
1998; Nelms et al. 1998; Lock et al. 1999). p56dok-2 is
closely related to p62dok and also binds to rasGAP and
Nck when tyrosine phosphorylated. However, dok-2
gene expression is not normally detectable in B cells
(Nelms et al. 1998).
In B lymphoma cell lines, a rasGAP-associated 62-kD
protein is tyrosine phosphorylated upon either BCR
cross-linking or BCR/FcgRIIB cocross-linking (Gold et
al. 1993; Vuica et al. 1997). Thus we examined tyrosine
phosphorylation of p62dok in primary B cells after these
treatments. When mouse splenic B cells were stimulated
with the F(ab8)2 form of rabbit IgG to mouse IgM, which
crosslinks only BCR (membrane IgM), p62dok was tyro-
sine phosphorylated within 2 min after cross-linking
(Fig. 2A). To our surprise, p62dok was more strongly
phosphorylated when B cells were stimulated with in-
tact rabbit IgG, which cocross-links BCR and FcgRIIB. In
both cases, p62dok was the most prominently phosphory-
lated band (Fig. 2B). Tyrosine phosphorylation of p62dok
after these treatments was hardly detected in B cells
from the lyn−/− mice at least during the early response
(Fig. 2C) (Nishizumi et al. 1995, 1998). This suggests that
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p62dok has a role downstream of the Src-like PTK Lyn in
both BCR- and FcgRIIB-mediated signaling. There are
several apparent target sites for Src-like PTK in p62dok
(Carpino et al. 1997; Yamanashi and Baltimore 1997) and
coexpression of it with Lyn in 293T cells induced hyper-
phosphorylation of p62dok (data not shown), suggesting
that Lyn may phosphorylate p62dok. B cells from lyn−/−
mice exhibit hyperproliferation to BCR or BCR/FcgRIIB
stimulation, along with enhanced MAP kinase activa-
tion and Ca2+ influx (Wang et al. 1996; Chan et al.
1997a,b; Nishizumi et al. 1998). This hyperresponsive-
ness is thought to be a cause of the autoimmune disease
that develops in lyn−/− mice (Hibbs et al. 1995; Nishi-
zumi et al. 1995). Thus, Lyn is a negative regulator of cell
proliferation, MAP kinase, and Ca2+ influx, suggesting
that p62dok acts at least partially as a novel signaling
molecule in pathways downstream of Lyn.
To address the function of p62dok, we examined the
proliferative response of splenic B cells from dok−/− mice
(Fig. 2D). Stimulation with F(ab8)2 to IgM induced prolif-
eration of B cells irrespective of dok gene inactivation.
However, stimulation with intact antibodies to IgM in-
duced proliferation of B cells only from the dok−/− mice.
In addition, pretreatment with mAb 2.4G2, which
blocks FcgRIIB, allowed intact antibody to induce pro-
liferation of wild-type B cells. These results indicate that
the pathway of negative regulation of BCR-mediated pro-
liferation by FcgRIIB is dysfunctional in dok−/− B cells at
least in these experimental conditions.
Because tyrosine phosphorylation of proteins upon
BCR stimulation is a critical event for subsequent cell
proliferation (DeFranco 1997; Kurosaki 1997; Reth and
Wienands 1997), p62dok might be expected to alter the
phosphorylation pattern when FcgRIIB is cross-linked to
BCR. However, except for phosphorylation of p62dok it-
self, overall tyrosine phosphorylation of proteins after
BCR or BCR/FcgRIIB stimulation was not substantially
altered by inactivation of the dok gene (Fig. 2Bb). Thus,
the inhibitory effect of p62dok occurs without affecting
the phosphorylation of major cellular substrates for ty-
rosine kinases.
Upon BCR stimulation, MAP kinase activation and
Ca2+ influx are induced and thought to be important
events (DeFranco 1997; Kurosaki 1997; Reth and Wien-
ands 1997). There are three reports on Dok family func-
tion in MAP kinase regulation. When p62dok was con-
stitutively overexpressed in a cell line, CHO-IR, which
also constitutively overexpresses insulin receptor, there
was a marked increase of membrane association of
rasGAP upon insulin stimulation (Noguchi et al. 1999).
However, the overexpression of p62dok did not signifi-
cantly affect MAP kinase activation upon insulin stimu-
lation of the CHO-IR cells. On the contrary, when
p56dok-2 was transiently overexpressed in a cell line,
32D, which also transiently overexpresses IL-2 receptor,
MAP kinase activation was suppressed upon IL-2 stimu-
lation of the cells (Nelms et al. 1998). Overexpression of
p56dok-2 also negatively regulated EGF receptor-medi-
ated activation of MAP kinase in COS1 cells (Jones and
Dumont 1999). Therefore, we first examined if the dok
gene inactivation in primary B cells affected MAP kinase
activity upon BCR cross-linking or cocross-linking of
BCR with FcgRIIB. Active Erk1 or Erk2 MAP kinases can
be detected by their phosphorylation on both threonine
and tyrosine residues in the TEY motif. We used a mAb
to the active/phosphorylated form of Erk (P-Erk) to
monitor its activation. Because Erk1 activation was very
weak upon BCR stimulation (data not shown), we fo-
cused on Erk2. As reported previously, Erk2 activation
was suppressed by costimulation of FcgRIIB with intact
IgG (Fig. 3A; Chan et al. 1997a). However, B cells pre-
pared from dok−/− spleen showed higher Erk2 activation
than normal cells upon BCR/FcgRIIB cocross-linking. In
addition, Erk2 was also activated to a higher extent in
the dok-null B cells than in normal cells even when BCR
alone was cross-linked. These results indicate that
p62dok is a negative regulator of MAP kinase upon cross-
linking of BCR or BCR with FcgRIIB.
Because p120 rasGAP was associated with p62dok
upon either BCR or BCR/FcgRIIB stimulation (Fig. 3B),
p21ras, an upstream positive regulator of MAP kinase,
may be suppressed by rasGAP. However, it was reported
recently that overexpression of a mutant p56dok-2 that
could not bind to either SH2 of rasGAP in vitro could
still attenuate MAP kinase (Jones and Dumont 1999).
The molecular basis of Dok family suppression of MAP
kinase awaits further analysis. On the other hand, even
in dok−/− B cells, Erk2 activation following BCR stimu-
lation was still suppressed by cocross-linking it with
Figure 1. Generation of dok-null-mutant mice. (A) Restriction
map of wild-type allele, targeting vector, and null allele of the
dok gene. Positions of exons covering the entire coding region
and of the initiation and stop codons are indicated by shaded
boxes and arrows, respectively. The dok probe used for Southern
blotting, as well as for thymidine kinase (TK) and neomycin-
resistant (neo) genes are indicated. (Stu) StuI; (Hd) HindIII; (Bam)
BamHI. (B) Southern blot analysis of genomic DNA isolated
from dok+/+, dok+/−, and dok−/− mice. BamHI-digested genomic
DNA was hybridized with the dok probe. Wild-type (5.2-kb) and
recombinant (4.2-kb) bands are indicated. (C) Absence of Dok
protein in dok−/− mice. NP-40-soluble proteins (50 µg) from
dok+/+ and dok−/− spleens are subjected to immunoblot analysis
with mAb to p62dok. Immunoglobulin heavy chain (IgH) in the
lysates reactive to the secondary antibody are indicated.
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FcgRIIB (Fig. 3A), suggesting that there is another mol-
ecule also suppressing MAP kinase downstream of
FcgRIIB. SHIP might be the other negative regulator of
MAP kinase, although that is yet controversial. (Liu et
al. 1998, 1999; Okada et al. 1998).
Tyrosine phosphorylation of the ITIM (Immunorecep-
tor Tyrosine-based Inhibitory Motif) of FcgRIIB and sub-
sequent association of SHIP to the motif are critical
events for FcgRIIB-mediated inhibition of Ca2+ influx
and cell proliferation (Ono et al. 1997; Ravetch 1997;
Figure 3. Role of p62dok in negative regulation of MAP kinase and
[Ca2+]i by FcgRIIB. (A) p62dok-dependent negative regulation of Erk2.
dok−/− or wild-type B cells were stimulated with the intact (Ig) or
F(ab8)2 form of antibody (30 µg/ml) to IgM for the indicated time.
Immunoprecipitated Erk2 (from 4 × 106 cells) was subjected to im-
munoblotting with mAb to P-Erk2 and reprobed with antibody to
Erk2. Positions of P-Erk2 (oval) and Erk2 (rectangle) are indicated (top
panels). At each time point, the phosphorylation level of Erk2 was
quantitated and normalized to the amount of immunoprecipitated
Erk2 (bottom panel). The normalized phosphorylation level of Erk2
of dok−/− B cells at 5 min after BCR stimulation was defined as 10 in
arbitrary units. (B) Association of rasGAP to p62dok. C57BL/6 B cells
were stimulated with the intact (Ig-2) or F(ab8)2 form (F-2) of antibody
(30 µg/ml) to IgM for 2 min or unstimulated (0). Proteins in anti-
p62dok immunoprecipitates (from 1.5 × 107 cells) (Dok-IP) or total
lysates (from 4 × 105 cells) (lysate) were subjected to immunoblotting
with the mAb to rasGAP. The position of rasGAP is indicated. (C)
Tyrosine phosphorylation of FcgRIIB in dok−/− B cells. dok−/− or
wild-type B cells were stimulated with the intact (Ig) or F(ab8)2 form
of antibody (30 µg/ml) to IgM for the indicated time. Immunopre-
cipitated FcgRIIB (from 3 × 106 cells) was subjected to immunoblot-
ting with RC20–HRP to detect tyrosine phosphorylation. (D) Asso-
ciation of SHIP with FcgRIIB in dok−/− B cells. B cells were stimu-
lated with intact antibody to IgM for 2 min (2) or unstimulated (0).
Proteins in anti-FcgRIIB immunoprecipitates (from 1 × 107 cells)
(FcgRIIB-IP) or total lysates (from 2 × 105 cells) (lysate) were sub-
jected to immunoblotting with antibody to SHIP or FcgRIIB. The
FcgRIIB–IP blotting with antibody to FcgRIIB was visualized sepa-
rately from the total lysate blotting. Positions of SHIP and FcgRIIB
are indicated. (E) Negative regulation of [Ca2+]i in dok−/− B cells.
dok−/− or wild-type B cells, which were loaded with fura-2, were
stimulated with the intact (dotted line) or F(ab8)2 (solid line) form of
antibody (30 µg/ml) to IgM at t = 0 min. [Ca2+]i was calculated based
on the fluorescence of fura-2 bound to Ca2+.
Figure 2. Lyn-dependent tyrosine phosphorylation of
p62dok and its role in B-cell proliferation upon BCR or
BCR/FcgRIIB stimulation. (A,B) Tyrosine phosphorylation
of p62dok. Wild-type or dok−/− B cells were stimulated with
the intact (Ig) or F(ab8)2 form of antibody (30 µg/ml) to IgM
for the indicated time. Immunoprecipitated p62dok (from
6 × 106 cells) (IP:Dok) or total lysate (from 2 × 105 cells) of
the B cells was subjected to immunoblotting with the mAb
to p62dok (IB:Dok) or with RC20–HRP to detect phospho-
tyrosine (IB:PY). Positions of p62dok and standard protein
markers (in kD) are indicated. (C) Lyn-dependent phos-
phorylation of p62dok. lyn−/− or wild-type (C57BL/6) B cells
were stimulated with the intact (Ig-) or F(ab8)2 (F-) form of
antibody (30 µg/ml) to IgM for the indicated time. Immu-
noprecipitated p62dok (from 3 × 106 cells) (IP:Dok) or total
lysate (from 3 × 105 cells) of the B cells was subjected to
immunoblotting with the mAb to p62dok (IB:Dok) or with
RC20–HRP (IB:PY). The position of p62dok is indicated. (D)
Effect of dok gene inactivation in B-cell proliferation.
dok−/− (d) or wild-type (s) B cells were stimulated with the
intact (Ig) or F(ab8)2 form of antibody (30 µg/ml) to IgM for
2 days in the presence (+) or absence (−) of pretreatment of
mAb 2.4G2 to FcgRIIB. [3H]TdR incorporation for the last
8 hr of culture was measured (counts/3 min).
Negative signaling mediated by p62dok
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Bolland et al. 1998; Coggeshall 1998; Liu et al. 1998;
Scharenberg et al. 1998). Thus, p62dok might be involved
in the FcgRIIB/SHIP pathway. However, we found that
p62dok is dispensable for FcgRIIB phosphorylation and its
subsequent binding to SHIP upon BCR/FcgRIIB stimu-
lation (Fig. 3C,D). Also, increase of intracytoplasmic
Ca2+ concentration ([Ca2+]i) following BCR cross-linking
was suppressed to substantially the same extent by
FcgRIIB engagement irrespective of the presence of
p62dok (Fig. 3E). As reported previously for wild-type B
cells (Chan et al. 1997b; Nishizumi et al. 1998), intracel-
lular released Ca2+, as judged by the relative [Ca2+]i in
the presence of EGTA in the medium returned to a basal
level within 5 min after BCR or BCR/FcgRIIB stimula-
tion in both dok−/− and wild-type B cells (data not
shown). Thus, p62dok does not appear to be either a regu-
lator or an effector of SHIP in the negative regulation of
Ca2+ influx upon BCR/FcgRIIB cocross-linking.
FcgRIIB null mice show a relative enhancement of an-
tibody production following both thymus-dependent
(TD) and -independent (TI) antigen stimulation (Takai et
al. 1996). However, Ship−/− lymphocytes reconstituted
in Rag-1−/− mouse showed normal antibody production
to vesicular stomatitis virus stimulation (Bolland et al.
1998). Therefore, SHIP is unlikely to be fully responsible
for FcgRIIB-mediated negative signaling. The same was
true of p62dok; dok-null mice had normal levels of IgG1
production to a TD antigen (Fig. 4A). In addition, dok-
null mice showed normal levels of IgM and IgG1 produc-
tion to TI antigens (data not shown). Unexpectedly, the
level of IgM production to the TD antigen in the dok−/−
mice was lower than in wild-type controls (Fig. 4A). Con-
sistently, total IgM levels in unstimulated dok−/− mice
were also lower than in wild-type controls (Fig. 4B).
Apart from this phenotype, however, p62dok is unlikely
to be fully responsible for FcgRIIB-mediated negative sig-
naling. Either SHIP or p62dok might be sufficient, possi-
bly in cooperation with other molecule(s), in balancing
immunoglobulin production.
Because p62dok is phosphorylated downstream of mul-
tiple growth factor receptors, and its tyrosine phosphory-
lation correlates with the transforming activity of Bcr-
Abl (Carpino et al. 1997; Yamanashi and Baltimore 1997;
Bhat et al. 1998; White and Yenush 1998), we had ex-
pected that p62dok would be a positive regulator of cell
proliferation. Its relative, IRS-1, has a positive role in
insulin receptor signaling. However, our data show that
p62dok, at least in B cells, is a negative regulator of MAP
kinase and cell proliferation. It appears that p62dok could
be important for negatively regulating the strength of
signals downstream of many PTKs. In this regard, it is
important that overexpression of p56dok-2 negatively
regulates MAP kinase activity in a cell lines (Nelms et
al. 1998; Jones and Dumont 1999). Because p62dok and
p56dok-2 are two major tyrosine-phosphorylated proteins
in bcr-abl-positive primary CML cells (Carpino et al.
1997; Nelms et al. 1998), they may have a role in the
establishment of the chronic phase of human CML by
negatively regulating signal(s) from Bcr–Abl.
Materials and methods
Generation of dok-null-mutant mice
Murine dok genomic DNA fragments were obtained from a
129/SVJ mouse genomic library by screening with a fragment
(1–448) of the murine dok cDNA (GenBank accession no.
U78818). To construct the targeting vector, a 2.6-kb HindIII–
HindIII 58 fragment and a 6.8-kb StuI–StuI 38 fragment were
placed into the XhoI and PmeI sites of pPNT plasmid (Ty-
bulewicz et al. 1991), respectively. This vector was linearized by
digestion with PacI and electroporated into J1 ES cells, which
were selected with G418 and Gancyclovir. Southern blot analy-
sis identified 5 recombinant clones with a single targeted allele
among 326 clones. Targeted cells were injected into fertilized
blastocysts from C57BL/6 female mice. Chimeric male mice
were crossed with C57BL/6 females for germ-line transmission.
Homozygotes were generated following heterozygous matings.
The absence of p62dok in homozygotes was confirmed by West-
ern blotting of solubilized proteins (prepared from spleens of 8-
to 11-week-old homozygous mice). All dok−/− and control mice
used were 8–11 weeks old with no splenomegaly, on a 129/
C57BL/6 background or otherwise noted. All mice were main-
tained under specific pathogen-free conditions.
Antibodies
MAb A-3 to mouse p62dok (Santa Cruz Biotechnology) was
raised against its amino-terminal portion (1–276) (Yamanashi
and Baltimore 1997). We confirmed that it reacts with p62dok
but not p56dok-2 by immunoblotting (data not shown). Rabbit
IgG to mouse IgM was affinity purified with µ-chain, and the
F(ab8)2 form of it was prepared as described (Kato et al. 1994).
mAb 2.4G2 to FcgRIIB was purified with protein A–Sepharose
from ascites. mAb HO-13-4 to Thy 1.2 was used in the form of
ascites. Recombinant variable region of the PY20-based mAb
RC20 to phosphotyrosine, conjugated with HRP (RC20–HRP),
was from Transduction Laboratory. Polyclonal antibodies to
Erk2 (C14), and to SHIP (N-1) were from Santa Cruz Biotech-
nology. Anti-mb1 rabbit antiserum used for FcgRIIB immuno-
blotting was a kind gift from J.V. Ravetch (Rockefeller Univer-
sity, New York, NY). mAbs to phospho-Erk (E10) and p120 ras-
GAP (B4F8) were from New England Biolabs and Santa Cruz
Biotechnology, respectively.
Figure 4. Low level of IgM production in dok−/− mice. (A) IgM
or IgG1 response to TD antigen. Relative DNP-specific IgM or
IgG1 levels in sera from wild-type(s) or dok
−/− (d) mice immu-
nized with DNP–hemocyanine were determined by ELISA, in
which the mean value of immunoglobulin levels in sera from
wild-type mice was defined as 1. Sera were prepared at day 7 or
day 14 postimmunization for IgM and IgG1, respectively. (B)
IgM or IgG1 concentrations (mg/ml) of preimmunization sera
from wild-type (s) or dok−/− (d) mice were determined by
ELISA.
Yamanashi et al.
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Preparation of resting B cells from spleen
Splenic B cells were prepared as described previously (Kato et al.
1994). Notably, all B cells used were purified with Percoll den-
sity gradient centrifugation, which enriched small resting B
cells, and the purified cells contained >95% surface Immuno-
globulin-positive B cells. The same expression level of the sur-
face FcgRIIB was confirmed on dok−/− B cells as on wild-type
controls by FACScan analysis (data not shown). With lyn−/− and
C57BL/6 B cells, they were prepared from 7-week-old mice, that
did not show any splenomegaly. The lyn−/− mice had been gen-
erated as described and backcrossed at least six generations to
C57BL/6 mice (Nishizumi et al. 1995, 1998).
Immunoprecipitation and immunoblotting
B cells (1 × 107) were suspended in 200 µl of minimal essential
medium (MEM) and incubated with intact or F(ab8)2 form of
rabbit IgG to mouse IgM for 0, 2, 5, or 30 min at 37°C. Cells
were then solubilized by adding 1 ml of 1.2× TNN buffer
(1× = 50 mM Tris at pH 8.0, 150 mM NaCl, 1% NP-40, 0.2 mM
sodium orthovanadate, 20 µg/ml aprotinin). The lysate was cen-
trifuged and the supernatant was precleared by treatment with
excess protein G–Sepharose. The cleared lysate was incubated
with 1–2 µg of antibody to p62dok, Erk2, or FcgRIIB for 1.5–3 hr,
and the immune complexes were precipitated with protein
G–Sepharose and washed five times with 1× TNN buffer. Pro-
teins in the immunoprecipitates or the cleared lysates were re-
solved by SDS-PAGE and transferred to PVDF membrane (Bio-
Rad). Immunoblotting was performed by standard methods and
visualized by chemiluminescence (NEN) or by alkaline phos-
phatase-based coloring (Promega). The identity of tyrosine-
phosphorylated p62dok in the cleared lysates (Fig. 2B) was veri-
fied by immunodepletion assay (data not shown). Quantitation
of P-Erk and Erk2 immunoblotting (Fig. 3A) was performed with
NIH Image software (v. 1.61).
B-cell proliferation assay
B cells (1 × 105) in 100 µl of RPMI-1640 medium, supplemented
with 10% FCS, 50 µM b-mercaptoethanol, and 100 µg/ml kana-
mycin, were cultured in a 96-well plate in the presence of the
intact or F(ab8)2 form of rabbit IgG to mouse IgM with or with-
out pretreatment with 10 µg/ml 2.4G2 mAb to FcgRIIB, which
was added to the culture at 30 min before anti-IgM stimulation.
Proliferation was evaluated by pulsing with 0.25 µCi [3H]thy-
midine ([3H]TdR, ICN Biochemicals) for the last 8 hr of the
culture. [3H]TdR incorporation was measured in a Matrix 96
system (Packard) and represented as the mean value of triplicate
assays as described (Kato et al. 1994). Standard deviation was
less than 5% of each readout.
[Ca2+]i assay
B cells (1 × 107 cells/ml) in MEM containing 0.025% BSA were
incubated with 4 µM fura-2AM at 37°C for 45 min. After wash-
ing three times, 2 × 106 fura-2-loaded B cells were suspended in
0.5 ml of the same medium and stimulated with the intact or
F(ab8)2 form of rabbit IgG to mouse IgM with stirring. Emission
at 500 nm was monitored under excitation of the sample at two
different wavelengths (340 and 380 nm) with a CAF-110 fluo-
rescence spectrophotometer (Japan Spectroscopic Co.). [Ca2+]i
was determined as described previously (Tamura and Nariuchi
1992).
Immunization and ELISA
Each 8- to 9-week-old mouse was immunized intraperitoneally
with 10 µg of dinitrophenyl (DNP)–hemocyanin in incomplete
Freund’s adjuvant (TD), 2 µg of DNP–Ficoll in PBS (TI), or 10 µg
of trinitrophenyl (TNP)–LPS in saline (TI) at day 0. Sera were
prepared at day 7 or day 14 postimmunization or preimmuni-
zation. Amounts of IgM or IgG1 in preimmunization sera were
determined by ELISA with isotype-specific antibody as de-
scribed previously (Nishizumi et al. 1995, 1998). For postimmu-
nization sera, relative amounts of IgM or IgG1 reacting with
DNP-conjugated BSA were determined by ELISA. At least seven
of nine dok−/− mice mounted IgM response to TD antigen (data
not shown).
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